Together with the observation that direct inhibition of mitochondrial metabolism is responsible for p53 genetic inactivation and increased tumourigenic potential19, our results support the notion that downregulation of several mitochondrial pathways is a common feature of the metabolic rewiring occurring in different cancer types. The gene discussed is TP53; the disease is cancer.